Premium
Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study
Author(s) -
D'Souza Anita,
Pasquini Marcelo,
Logan Brent,
Giralt Sergio,
Krishnan Amrita,
Antin Joseph,
Howard Alan,
Goodman Stacy,
Qazilbash Muzzafar,
Knust Kristin,
Sahebi Firoozeh,
Weisdorf Daniel,
Vesole David,
Stadtmauer Edward,
Maloney David,
Hari Parameswaran
Publication year - 2017
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.14170
Subject(s) - medicine , multiple myeloma , immunoglobulin light chain , oncology , transplantation , monoclonal gammopathy of undetermined significance , minimal residual disease , polyclonal antibodies , antibody , monoclonal , immunology , monoclonal antibody , bone marrow
Arber, D.A. & Hasserjian, R.P. (2015) Reclassifying myelodysplastic syndromes: what’s where in the new WHO and why. Hematology/the Education Program of the American Society of Hematology, 2015, 294–298. Cui, R., Gale, R.P., Xu, Z., Qin, T., Fang, L., Zhang, H., Pan, L., Zhang, Y. & Xiao, Z. (2012) Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts. Leukemia Research, 36, 1428–1433. Greenberg, P.L., Tuenchler, H., Schanz, J., Sanz, G., Garcia-Manero, G., Sol e, F., Bennett, J.M., Bowen, D., Fenaux, P. & Dreyfus, F. (2012) Revised international prognostic scoring system for myelodysplastic syndromes. Blood, 120, 2454–2465. Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (2001) Pathology and genetics of tumours of the haematopoietic and lymphoid tissues. IARC Press, France. Malcovati, L., Karimi, M., Papaemmanuil, E., Ambaglio, I., Jadersten, M., Jansson, M., Elena, C., Galli, A., Walldin, G., Della Porta, M.G., Raaschou-Jensen, K., Travaglino, E., Kallenbach, K., Pietra, D., Ljungstrom, V., Conte, S., Boveri, E., Invernizzi, R., Rosenquist, R., Campbell, P.J., Cazzola, M. & Hellstrom Lindberg, E. (2015) SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood, 126, 233–241. Mufti, G.J., Bennett, J.M., Goasguen, J., Bain, B.J., Baumann, I., Brunning, R., Cazzola, M., Fenaux, P., Germing, U., Hellstr€ om-Lindberg, E., Jinnai, I., Manabe, A., Matsuda, A., Niemeyer, C.M., Sanz, G., Tomonaga, M., Vallespi, T. & Yoshimi, A.; International Working Group on Morphology of Myelodysplastic Syndrome.(2008) Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica,93,1712–1717. Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J.S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., Godfrey, A.L., Rapado, I., Cvejic, A., Rance, R., McGee, C., Ellis, P., Mudie, L.J., Stephens, P.J., McLaren, S., Massie, C.E., Tarpey, P.S., Varela, I., Nik-Zainal, S., Davies, H.R., Shlien, A., Jones, D., Raine, K., Hinton, J., Butler, A.P., Teague, J.W., Baxter, E.J., Score, J., Galli, A., Della Porta, M.G., Travaglino, E., Groves, M., Tauro, S., Munshi, N.C., Anderson, K.C., El-Naggar, A., Fischer, A., Mustonen, V., Warren, A.J., Cross, N.C., Green, A.R., Futreal, P.A., Stratton, M.R. & Campbell, P.J. (2011) Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. New England Journal of Medicine, 365, 1384–1395. Swerdllow, S., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Press, France.